Replies to post #23350 on Cytodyn Inc (CYDY)

[finesand]

Maraviroc decreases CCL8-mediated migration of CCR5+ regulatory T cells and reduces metastatic tumor growth in the lung

2016 https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1150398

Looks like Pro 140 is trailing the movement, however, it probably has far less side-effects ..

So this is ViiV/GSK again w/ Maraviroc, let's see what Pfizer may desire .. (o8>